Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers Discover a Potential New Target for Cancer Treatment

05.05.2017

Inhibition of the enzyme RIOK1could stop the growth of tumors and the development of metastases

Dr. Florian Weinberg, from Prof. Dr. Tilman Brummer’s research group at the Institute of Molecular Medicine and Cell Research (IMMZ) of the University of Freiburg, joined forces with scientists from the Departments of Clinical Pathology and Medicine I of the University Medical Centre Freiburg and the Kinghorn Cancer Centre/Garvan Insitute in Australia in an international team that has identified a new target for cancer therapy.


Depicted are lung cancer cells stained for the cytoskeleton (colored in green) and the nuclei (colored in blue). A new therapeutic method may be able to reduce the growth and aggressiveness of these cells.

Source: Florian Weinberg

The researchers discovered that the enzyme RIOK1 collaborates with the RAS protein, which is often mutated in tumors and therefore promotes tumor growth and the development of metastases. These secondary tumors are spread by the primary tumor, if it is not removed in time, and are the cause of death in most cancer patients.

The researchers believe it may be possible to use so-called inhibitors to block the enzymatic activity of RIOK1, thereby slowing down the disease’s progression. The team has recently published its findings in the translational journal EBioMedicine.

Cancer diseases are characterized by gene mutations that cause the uncontrolled growth of the body's own cells. This, in turn, results in the development of tumors. Most treatments combine surgery to remove the tumor with chemotherapy or radiation therapy, both of which are used to inhibit the fast growth of cells. Specific inhibitors can also be used as an additional or alternative therapy.

These drugs inhibit the activity of the harmful proteins and enzymes produced by the mutated genes in tumors. However, there are currently only very few ways to specifically treat RAS-driven tumors. Because roughly 30 percent of all cancer patients carry a Ras mutation in their tumors, there is a very strong need to find new ways to target RAS.

The team of scientists studied the growth behavior of human RAS-mutated lung-, breast-, and colorectal cancer cells in cell culture and animal models. In each case, they were able to genetically modify the cells, so that they were no longer able to produce RIOK1, a method that mimics the effects of a still to be developed RIOK1 inhibitor. By this approach, the authors were able to reduce the growth and aggressiveness of the cancer cells.

Especially in the animal models, the researchers observed that the modified cells were no longer able to form metastases. RIOK1 belongs to the enzyme family of protein kinases for which inhibitors are already successfully used in cancer therapy. Therefore, the scientists believe that similar substances inhibiting the enzymatic activity of RIOK1 could be developed in the near future. In addition, RIOK1 could be used to predict the progression of lung and breast cancer more accurately, as the researchers observed an increased production of RIOK1 in the tumor tissue of patients who had a poorer prognosis.

The researchers stated that more studies are needed to confirm RIOK1 as a target for cancer therapy, however. It would be important, for example, to understand the exact mechanism through which the enzyme supports cancer growth and metastasis.

It is also essential that inhibitors be tested first on model organisms before the drugs can be tested in clinical studies. The researchers’ initial studies on roundworms and human cells have demonstrated that healthy body cells are either only partially affected or not affected at all by the loss of RIOK1, because they do not depend on the enzyme. This would mean that, at the same time, cancer cells would be inhibited from growing and from spreading new tumors.

The study was funded by the Cluster of Excellence BIOSS Centre for Biological Signalling Studies and the Collaborative Research Center 850 “Control of Cell Motility in Morphogenesis, Cancer Invasion and Metastasis” at the University of Freiburg.

Caption:
Depicted are lung cancer cells stained for the cytoskeleton (colored in green) and the nuclei (colored in blue). A new therapeutic method may be able to reduce the growth and aggressiveness of these cells.
Source: Florian Weinberg

Original Publication:
The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior.
Florian Weinberg, Nadine Reischmann, Lisa Fauth, Sanaz Taromi, Justin Mastroianni, Martin Köhler, Sebastian Halbach, Andrea C. Becker, Niantao Deng, Tatjana Schmitz, Franziska Maria Uhl, Nicola Herbener, Bianca Riedel, Fabian Beier, Alexander Swarbrick, Silke Lassmann, Jörn Dengjel, Robert Zeiser, Tilman Brummer
DOI: http://dx.doi.org/10.1016/j.ebiom.2017.04.015

Contact:
Prof. Dr. Tilman Brummer
Institute of Molecular Medicine and Cell Research
University of Freiburg
Phone: +49 (0)761 / 203 - 9610
E-Mail: tilman.brummer@zbsa.de

Weitere Informationen:

https://www.pr.uni-freiburg.de/pm-en/2017/researchers-discover-a-potential-new-t...

Rudolf-Werner Dreier | Albert-Ludwigs-Universität Freiburg im Breisgau

Further reports about: CANCER cancer cells cancer therapy enzymatic activity enzyme tumors

More articles from Life Sciences:

nachricht At last, butterflies get a bigger, better evolutionary tree
16.02.2018 | Florida Museum of Natural History

nachricht New treatment strategies for chronic kidney disease from the animal kingdom
16.02.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

Im Focus: Autonomous 3D scanner supports individual manufacturing processes

Let’s say the armrest is broken in your vintage car. As things stand, you would need a lot of luck and persistence to find the right spare part. But in the world of Industrie 4.0 and production with batch sizes of one, you can simply scan the armrest and print it out. This is made possible by the first ever 3D scanner capable of working autonomously and in real time. The autonomous scanning system will be on display at the Hannover Messe Preview on February 6 and at the Hannover Messe proper from April 23 to 27, 2018 (Hall 6, Booth A30).

Part of the charm of vintage cars is that they stopped making them long ago, so it is special when you do see one out on the roads. If something breaks or...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Fingerprints of quantum entanglement

16.02.2018 | Information Technology

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers

16.02.2018 | Health and Medicine

Hubble sees Neptune's mysterious shrinking storm

16.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>